1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 

The incidence of ITSS in each pathologic group of SELs
Pathologic DiagnosisITSS Degree
Grade 1 (%)Grade 2 (%)Grade 3 (%)
GBM0/25 (0)4/25 (16)21/25 (84)
AA3/5 (60)2/5 (40)0/5 (0)
Metastasis4/15 (27)5/15 (33)6/15 (40)
Lymphoma7/7 (100)0/7 (0)0/7 (0)
MS3/3 (100)0/3 (0)0/3 (0)
Granuloma9/9 (100)0/9 (0)0/9 (0)
  • 

    Note:—AA indicates anaplastic astrocytoma; ITSS, intratumoral susceptibility signal; SEL, solitary enhancing lesion; GBM, glioblastoma multiforme; MS, multiple sclerosis.